Cargando…

240. Reduction of antibiotic use in children admitted with viral respiratory tract infections

BACKGROUND: Viral respiratory tract infections (VRTI) accounts for a significant proportion of hospitalized children and contributes to a substantial use of health care resources and costs. American Academy of Pediatrics (AAP) recommends against using antibiotics in uncomplicated viral respiratory i...

Descripción completa

Detalles Bibliográficos
Autores principales: Dutta, Ankhi, Lo, Huay-Ying, Singh, Amrita, Mobeen, Samrah, Kulik, Kelli, James, Megan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7778306/
http://dx.doi.org/10.1093/ofid/ofaa439.284
_version_ 1783631104662568960
author Dutta, Ankhi
Lo, Huay-Ying
Singh, Amrita
Mobeen, Samrah
Kulik, Kelli
James, Megan
author_facet Dutta, Ankhi
Lo, Huay-Ying
Singh, Amrita
Mobeen, Samrah
Kulik, Kelli
James, Megan
author_sort Dutta, Ankhi
collection PubMed
description BACKGROUND: Viral respiratory tract infections (VRTI) accounts for a significant proportion of hospitalized children and contributes to a substantial use of health care resources and costs. American Academy of Pediatrics (AAP) recommends against using antibiotics in uncomplicated viral respiratory infections in children. Overuse of antibiotics ranges between 29–80%. The goal of an Antibiotic stewardship programs (ASP) is to decrease antibiotic misuse, lower costs, and prevent emergence of antibiotic resistance in the community. Proportion of children with Viral respiratory tract infections on antibiotics [Image: see text] METHODS: Our smart aim was to reduce antibiotic use by 25% in admitted children with VRTI between October 2019-March 2020. Our outcome measure was to reduce inappropriate antibiotic use during the 2019–20 season by 25%. Process measures included percentage of antibiotic used in viral RTI, antibiotic days of therapy and appropriate audit-feedback from the ASP team to facilitate discontinuation or de-escalation of antibiotics based on culture data. Our balance measure included readmission rates in patients in whom antibiotics were discontinued or de-escalated. Several PDSA cycles implemented with predominant emphasis on communication between ASP team and primary providers. RESULTS: No differences were noted in patient demographics including sex, age, ethnicity between the viral season in 2018–19 and 2019–2020. In our previous study in 2018–2019 RSV season, there was 40.7% antibiotic use in patients admitted with RSV bronchiolitis. In 2019–2020 season we included all patients admitted with viral RTI. Of the 213 patients evaluated between October 2019 through Dec 2020, 40% of the patients received antibiotics. 100% of the antibiotics were justified, based on independent review of antibiotic data by the team. Most common cause of antibiotics were community acquired pneumonia, rule out sepsis and otitis media. Antibiotic discontinuation and de-escalation were achieved in over 90% of the justified antibiotics. CONCLUSION: Though antibiotic usage was still at 40% at our institution, 100% of antibiotic use was deemed appropriate and significant proportion were discontinued or deescalated by the ASP team. The ASP team played a crucial role in communicating with the primary providers to advocate for appropriate antibiotic use in the children. DISCLOSURES: All Authors: No reported disclosures
format Online
Article
Text
id pubmed-7778306
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-77783062021-01-07 240. Reduction of antibiotic use in children admitted with viral respiratory tract infections Dutta, Ankhi Lo, Huay-Ying Singh, Amrita Mobeen, Samrah Kulik, Kelli James, Megan Open Forum Infect Dis Poster Abstracts BACKGROUND: Viral respiratory tract infections (VRTI) accounts for a significant proportion of hospitalized children and contributes to a substantial use of health care resources and costs. American Academy of Pediatrics (AAP) recommends against using antibiotics in uncomplicated viral respiratory infections in children. Overuse of antibiotics ranges between 29–80%. The goal of an Antibiotic stewardship programs (ASP) is to decrease antibiotic misuse, lower costs, and prevent emergence of antibiotic resistance in the community. Proportion of children with Viral respiratory tract infections on antibiotics [Image: see text] METHODS: Our smart aim was to reduce antibiotic use by 25% in admitted children with VRTI between October 2019-March 2020. Our outcome measure was to reduce inappropriate antibiotic use during the 2019–20 season by 25%. Process measures included percentage of antibiotic used in viral RTI, antibiotic days of therapy and appropriate audit-feedback from the ASP team to facilitate discontinuation or de-escalation of antibiotics based on culture data. Our balance measure included readmission rates in patients in whom antibiotics were discontinued or de-escalated. Several PDSA cycles implemented with predominant emphasis on communication between ASP team and primary providers. RESULTS: No differences were noted in patient demographics including sex, age, ethnicity between the viral season in 2018–19 and 2019–2020. In our previous study in 2018–2019 RSV season, there was 40.7% antibiotic use in patients admitted with RSV bronchiolitis. In 2019–2020 season we included all patients admitted with viral RTI. Of the 213 patients evaluated between October 2019 through Dec 2020, 40% of the patients received antibiotics. 100% of the antibiotics were justified, based on independent review of antibiotic data by the team. Most common cause of antibiotics were community acquired pneumonia, rule out sepsis and otitis media. Antibiotic discontinuation and de-escalation were achieved in over 90% of the justified antibiotics. CONCLUSION: Though antibiotic usage was still at 40% at our institution, 100% of antibiotic use was deemed appropriate and significant proportion were discontinued or deescalated by the ASP team. The ASP team played a crucial role in communicating with the primary providers to advocate for appropriate antibiotic use in the children. DISCLOSURES: All Authors: No reported disclosures Oxford University Press 2020-12-31 /pmc/articles/PMC7778306/ http://dx.doi.org/10.1093/ofid/ofaa439.284 Text en © The Author 2020. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Poster Abstracts
Dutta, Ankhi
Lo, Huay-Ying
Singh, Amrita
Mobeen, Samrah
Kulik, Kelli
James, Megan
240. Reduction of antibiotic use in children admitted with viral respiratory tract infections
title 240. Reduction of antibiotic use in children admitted with viral respiratory tract infections
title_full 240. Reduction of antibiotic use in children admitted with viral respiratory tract infections
title_fullStr 240. Reduction of antibiotic use in children admitted with viral respiratory tract infections
title_full_unstemmed 240. Reduction of antibiotic use in children admitted with viral respiratory tract infections
title_short 240. Reduction of antibiotic use in children admitted with viral respiratory tract infections
title_sort 240. reduction of antibiotic use in children admitted with viral respiratory tract infections
topic Poster Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7778306/
http://dx.doi.org/10.1093/ofid/ofaa439.284
work_keys_str_mv AT duttaankhi 240reductionofantibioticuseinchildrenadmittedwithviralrespiratorytractinfections
AT lohuayying 240reductionofantibioticuseinchildrenadmittedwithviralrespiratorytractinfections
AT singhamrita 240reductionofantibioticuseinchildrenadmittedwithviralrespiratorytractinfections
AT mobeensamrah 240reductionofantibioticuseinchildrenadmittedwithviralrespiratorytractinfections
AT kulikkelli 240reductionofantibioticuseinchildrenadmittedwithviralrespiratorytractinfections
AT jamesmegan 240reductionofantibioticuseinchildrenadmittedwithviralrespiratorytractinfections